The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal HemoglobinuriaPeter Hillmen, Lucio Luzzatto, Neal S. Young et al.|New England Journal of Medicine|2006Cited by 1.3k
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuriaRobert A. Brodsky, Peter Hillmen, Henk-André Kroon et al.|Blood|2007Cited by 653
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuriaPeter Hillmen, Neal S. Young, Petra Muus et al.|Blood|2007Cited by 578
Deficiency of Innate and Acquired Immunity Caused by an <i>IKBKB</i> MutationUlrich Pannicke, Klaus Schwarz, Bernd Baumann et al.|New England Journal of Medicine|2013Cited by 184
Similar outcome of upfront‐unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the <scp>UK</scp> Paediatric <scp>BMT</scp> Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of <scp>EBMT</scp>Carlo Dufour, Sujith Samarasinghe, Paul Veys et al.|British Journal of Haematology|2015Cited by 182